Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenJesper Pallesen, Jason S. McLellan, Robert N. Kirchdoerfer et al.|Proceedings of the National Academy of Sciences|2017Cited by 1.2k
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S. Corbett, Tracy J. Ruckwardt, Darin K. Edwards et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 143